Changing trends in the landscape of patients hospitalized with acute myocardial infarction (2001 to 2011): The Worcester Heart Attack Study by Mercado-Lubo, Regino
University of Massachusetts Medical School 
eScholarship@UMMS 
GSBS Dissertations and Theses Graduate School of Biomedical Sciences 
2019-06-28 
Changing trends in the landscape of patients hospitalized with 
acute myocardial infarction (2001 to 2011): The Worcester Heart 
Attack Study 
Regino Mercado-Lubo 
University of Massachusetts Medical School 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/gsbs_diss 
 Part of the Cardiology Commons, Cardiovascular Diseases Commons, Clinical Epidemiology 
Commons, and the Epidemiology Commons 
Repository Citation 
Mercado-Lubo R. (2019). Changing trends in the landscape of patients hospitalized with acute myocardial 
infarction (2001 to 2011): The Worcester Heart Attack Study. GSBS Dissertations and Theses. 
https://doi.org/10.13028/j61r-ks88. Retrieved from https://escholarship.umassmed.edu/gsbs_diss/1033 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in GSBS Dissertations and 
Theses by an authorized administrator of eScholarship@UMMS. For more information, please contact 
Lisa.Palmer@umassmed.edu. 
CHANGING TRENDS IN THE LANDSCAPE OF PATIENTS HOSPITALIZED WITH 
ACUTE MYOCARDIAL INFARCTION (2001 to 2011): THE WORCESTER HEART 
ATTACK STUDY  
 







Submitted to the Faculty of the 
University of Massachusetts Graduate School of Biomedical Sciences, Worcester in 
partial fulfillment of the requirements for the degree of 
 
MASTER OF SCIENCE IN CLINICAL INVESTIGATION 
 
 
June 28, 2019 
 
 
     ii 
CHANGING TRENDS IN THE LANDSCAPE OF PATIENTS HOSPITALIZED WITH 
ACUTE MYOCARDIAL INFARCTION (2001 to 2011): THE WORCESTER HEART 
ATTACK STUDY  
A Masters Thesis Presented  
By 
REGINO MERCADO-LUBO 
The signatures of the Master’s Thesis Committee signify completion and approval as to 
style and content of the Thesis 
 
Sharina Person Ph.D., Chair of Committee 
 
William Jesdale Ph.D., Member of Committee 
 
Joel Gore MD, Member of Committee 
 
The signature of the Dean of the Graduate School of Biomedical Sciences signifies that 
the student has met all master’s degree graduation requirements of the school. 
 
 
Marry Ellen Lane, Ph.D., 
Dean of the Graduate School of Biomedical Sciences 
 
Master of Science Degree in Clinical Investigation (MSCI) 
June 28, 2019 
     iii 
ACKNOWLEDGEMENT 
 
I would like to express my appreciation to my thesis advisor, Dr. Robert Goldberg, for his 
support and the mentorship he provided to me, from the time I was considering applying 
to the MSCI program, through to completion of this degree. His meticulous scrutiny and 
timely advice throughout my time in the MSCI program were instrumental in my 
development as a clinical investigator. I would also like to thank the members of my 
Master’s Thesis Committee, Dr. Sharina Person, Dr. Joel Gore and Dr. William Jesdale, 
for their guidance and participation in my thesis review process. 
Finally, I owe a deep sense of gratitude to long-time mentor, Dr. Beth McCormick, for 
her continuous support and dedication to my personal and intellectual growth, during the 
time I have worked under her guidance. Her intellectual heft and scientific integrity are 
only second to her genuinely good nature, and I am truly fortunate to have the 








     iv 
ABSTRACT 
 
Background: During the past several decades, novel diagnostic tools, interventional 
approaches, and population-wide changes in the major coronary risk factors have 
occurred. However, few studies have examined relatively recent trends in  the 
demographic characteristics, clinical profile, and the short-term outcomes of patients 
hospitalized for acute myocardial infarction (AMI) from the more generalizable 
perspective of a population-based investigation. 
Methods: We examined decade long trends (2001 to 2011) in patient’s demographic and 
clinical characteristics, treatment practices, and hospital outcomes among residents of the 
Worcester metropolitan area hospitalized with an  initial AMI (n = 3,730) at all 11 greater 
Worcester medical centers during 2001, 2003, 2005, 2007, 2009, and 2011. 
Results: The average age of the study population was 68.5 years and 56.9% were men. 
Patients hospitalized with a first AMI during the most recent study years were 
significantly younger (mean age = 69.9 years  in 2001/03; 65.2  years in 2009/11), had 
lower serum troponin levels, and experienced a shorter hospital stay compared with 
patients hospitalized during the earliest study years. Hospitalized patients were more 
likely to received evidence-based medical management practices during the years under 
study. Multivariable-adjusted regression models showed a considerable decline over-time 
in the hospital death rate and a significant reduction in the proportion of patients who 
developed atrial fibrillation, heart failure, and ventricular fibrillation during their acute 
hospitalization. 
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Conclusions: These results highlight the changing nature of patients hospitalized with an 
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Despite more than 50 years of significant therapeutic advances and population-
wide lifestyle changes in several predisposing factors, acute myocardial infarction (AMI) 
continues to be a major cause of morbidity and mortality, being responsible for more than 
150,000 deaths and nearly one million hospitalizations annually in the U.S.1, 2. 
 
A limited number of longitudinal, community-based, observational studies have 
described changes over time in the clinical epidemiology and outcomes of patients 
hospitalized with AMI in the U.S. 3. Investigators from the Worcester Heart Attack Study 
have described multi-decade long trends in the epidemiology of AMI among residents of 
the Worcester, Massachusetts, metropolitan area hospitalized with AMI at all central 
Massachusetts medical centers on an approximate biennial basis 4, 5,  while the Minnesota 
Heart Survey has monitored trends in the magnitude of AMI and out-of-hospital cardiac 
deaths among residents of the seven county Minneapolis/St. Paul metropolitan area 
between 1980 and 2002 6, 7. The Rochester Epidemiology Project, through use of a 
comprehensive medical records linkage system, has examined the occurrence and 
outcomes of AMI among residents of Olmsted County, Minnesota on an annual basis 
between 1966 and 2012 8, 9. 
 
The introduction of newer diagnostic tools and laboratory biomarkers, new 
cardiac   therapies and interventional approaches, as well as population-wide changes in 
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the major coronary predisposing factors have impacted the descriptive epidemiology of 
AMI and its in-hospital and post-discharge outcomes. However, few relatively recent 
data exist describing the potentially changing landscape of AMI at the community level.  
  
The primary objective of this population-based study was to describe decade long 
trends in the sociodemographic and clinical characteristics, hospital management 
practices, and in-hospital  clinical outcomes among residents of central Massachusetts 
hospitalized with a first AMI at all 11 metropolitan Worcester medical centers on a 




















A. Study population.  
Details of the Worcester Heart Attack Study have been previously described 10. Briefly, 
residents of the Worcester metropolitan area hospitalized with a primary or secondary 
discharge diagnosis of AMI (International Classification of Disease [ICD-9] code 410) at 
all 11 Worcester standard metropolitan statistical area (SMSA) hospitals during 2001, 
2003, 2005, 2007, 2009, and 2011 comprised the study population. 
 
B. Data collection.  
The medical records of residents of central Massachusetts hospitalized with a possible 
AMI were individually reviewed and validated according to pre-established criteria10-13. 
In brief, these criteria included a clinical history of prolonged chest pain not relieved by 
rest or use of nitrates, serum enzyme level elevations in excess of the upper limit of 
normal as specified by the laboratory at each hospital, and serial electrocardiographic 
tracings during hospitalization showing changes in the ST-segment typical of AMI. At 
least two of these three criteria needed to be satisfied for study inclusion. Additionally, 
sociodemographic, medical history, and clinical data were abstracted from the hospital 
medical records of geographically eligible patients by trained study physicians and 
nurses. Information was collected about patient’s age, sex, co-morbidities (e.g., angina, 
diabetes, heart failure, hypertension, or stroke), AMI type (ST-segment elevation vs. non-
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ST-segment elevation), and occurrence of clinically significant hospital complications 
including atrial fibrillation, heart failure, cardiogenic shock, and hospital survival status 4, 
5, 10, 11. Patients with a history of  AMI were excluded from the present study in order to 
provide descriptive insights to the natural history of AMI among patients with a first 
confirmed AMI. Information was collected about the prescribing of different cardiac 
medications including the hospital use of aspirin, angiotensin-converting enzyme 
inhibitors, beta blockers, calcium antagonists, diuretics, lipid-lowering agents, and 
thrombolytic therapy. Data were also collected about the receipt of various coronary 
diagnostic and interventional procedures including cardiac catheterization, percutaneous 
transluminal coronary intervention, and coronary artery bypass graft surgery. 
 
C. Data analysis. 
 To facilitate the interpretation of decade long trends in the descriptive epidemiology of 
AMI, the 6 one-year study years were aggregated into 3 two-year time periods. These 
aggregated periods consisted of  2001 and 2003, 2005 and 2007, and 2009 and 2011. 
Differences in the distribution of various demographic factors, medical history, 
physiologic findings, clinical characteristics, and treatment practices among patients 
hospitalized with an initial AMI during the years under study were examined with chi-
square tests for trends and analysis of variance for discrete and continuous variables 
respectively. To assess changes over time in the occurrence of important clinical 
complications and in-hospital case-fatality rates, while controlling for several potentially 
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confounding demographic and clinical factors of prognostic importance, several logistic 














































A. Study population. 
The present report is based on the 3,730 residents of the Worcester metropolitan area who 
satisfied the diagnostic criteria for an initial AMI in the 6 calendar years examined. The 
mean age of study patients was 68.5 years, 43.1% were women, and 89.9% were white. 
 
Patients hospitalized with a first AMI during the most recent study years were 
significantly younger compared with patients who had been hospitalized in the earliest 
study years (Table 1). There were a greater proportion of individuals with previously 
diagnosed anemia, chronic kidney disease, hyperlipidemia, hypertension, and peripheral 
vascular disease during the most recent as compared with earlier study years. A modest 
decrease in mean systolic blood pressure and estimated glomerular filtration rate (eGFR) 
values was observed over time. There was a decline in the mean serum Troponin levels at 
the time of hospital admission as well as in the average length of hospital stay during the 
decade long period under study (Table 1).  
 
B. Trends in hospital medication practices and coronary interventions.  
The in-hospital use of aspirin and lipid lowering agents increased markedly during the 
years under study (Figure 1). A statistically significant, but inconsistent, increase in the 
use of beta blockers was observed during the years under study while there was a marked  
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Table 1 
Characteristics of Patients Hospitalized with an Initial Acute 
Myocardial Infarction According to Time Period of Hospitalization 
 
Characteristic 2001/03 







Age (yrs), mean  69.9 69.3 65.2  
Age, years (%)      
<55 17.8  19.1  22.0   
55 - 64 17.5  16.8  21.5   
65 - 74 20.9  17.9  19.9   
75 - 84 27.2  27.1  18.3   
≥85 16.7  19.1  18.3  < 0.001  
Male, %  56.9  54.9  59.1  0.09 
White, %  87.9  90.6  91.9  < 0.001 
Medical History %      
Angina 16.7  8.9  4.1  < 0.001 
Anemia 4.5  11.8  10.0  < 0.001 
CKD 11.8  17.5  18.0  <0.001 
COPD 15.0  16.5  12.2  <0.005 
Diabetes 28.0  28.8  31.7  0.33 
Heart Failure 15.0  16.5  12.2  <0.005 
Hyperlipidemia 44.2  55.6  65.6  < 0.001 
Hypertension 65.0  70.6  69.6  <.01 
PVD 11.6  16.3 16.3  < 0.001 
Stroke 
 
9.3  9.2  7.5  0.42 
Laboratory/Physiologic 
Findings 
    
Systolic BP in   (mean, mmHg) 143.2 142.1 140.4 0.08 
Diastolic BP (mean, mmHg) 78.8 78.2 79.0 0.08 
eGFR 59.7  62.1  53.9  < 0.001 
Serum Glucose (mean, mg/dl) 168.6  163.3 166.9 0.20 
ST-segment elevation, % 38.5 35.4 34.5 0.08 
Troponin I, Mean 34.3  11.7 9.4 <0.001 
Length of stay, (Mean, days)  5.9 5.7 4.6  <0.001 
 
(CKD = Chronic kidney disease; COPD = chronic obstructive pulmonary disease; PVD = peripheral 
vascular disease) 
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decrease in the use of calcium channel blockers, diuretics, and thrombolytic therapy over 
time; the use of angiotensin-converting enzyme inhibitors remained essentially 
unchanged during the period under study (Figure 1). The proportion of patients who 
underwent diagnostic cardiac catheterization and a percutaneous coronary intervention 
(PCI) increased markedly between 2001 and 2011. In 2009/11, the percentage of 
hospitalized patients that received diagnostic catheterization or a percutaneous coronary 
intervention was 72.0% and 54.7%, respectively (Figure 2). Moreover, changes over time 
in the utilization of coronary revascularization procedures following a diagnostic cardiac 
catheterization were observed (Figure 3). The proportion of patients who underwent a 
subsequent PCI increased significantly over time, while the proportion of patients who 
underwent coronary artery bypass surgery  during their acute hospitalization declined 
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Figure 1 













































(ACE = angiotensin-converting-enzyme; ARBs = angiotensin II receptor blocker )
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Figure 2 




































(CABG = coronary artery bypass grafting; PCI = percutaneous coronary intervention)
Catheterization
     11 
Figure 3 









































(CABG = coronary artery bypass grafting; PCI = percutaneous coronary intervention)
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C. Trends in hospital clinical complications and case-fatality rates.   
Changes over time in the occurrence of several major in-hospital complications and all-
cause in-hospital mortality were evaluated. We observed a progressive decline in the 
proportion of patients who developed ventricular fibrillation, atrial fibrillation, or heart 
failure during the years under study as well as a marked decrease in hospital death rates 
(Table 2). No significant changes in the occurrence of cardiogenic shock or stroke during 
the patient’s acute hospitalization were found (Table 2).   
 
Both crude and multivariable adjusted regression analyses were performed to more 
systematically examine trends in hospital death rates and in the occurrence of the major 
clinical complications examined  while controlling for a number of potentially 
confounding demographic and clinical factors of prognostic importance (Table 5).  
Results of the unadjusted analysis (model 1) showed significant declines over time in the 
odds of dying in the hospital while declines in the odds of developing atrial fibrillation, 
heart failure, and ventricular fibrillation were also noted.  These results essentially 
remained after adjusting for patient demographic characteristics, occurrence of 
concomitant clinical complications, as well as AMI type (STEMI vs NON-STEMI) and 
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Table 2 





(n = 1,547) 
% 
2005/07 
(n = 1,170) 
% 
2009/11 
(n = 1,013) 
% 
P value 
Atrial Fibrillation 21.7 21.5 15.1 0.003 
Cardiogenic Shock 4.9 6.1 4.6 0.87 
Death 9.6 9.8 6.5 0.003 
Heart Failure 34.4 33.9 28.2 0.014 
Stroke 1.7 0.6 1.8 0.88 
Ventricular 
Fibrillation 













































The results of our large population-based study highlight the changing landscape of 
patients hospitalized with AMI at all teaching and community medical centers in central 
Massachusetts. We found significant changes in the demographic characteristics, clinical 
profile, and in-hospital management of patients who were hospitalized with a first AMI. 
Moreover, encouraging declines in the proportion of patients who died or experienced 
major clinical complications during their acute hospitalization were observed. 
Changes in patient’s demographic and clinical characteristics.  Residents of the 
Worcester metropolitan area hospitalized with an independently confirmed initial AMI 
during the most recent study years were significantly younger and more likely to be men 
compared with patients hospitalized during the initial years under investigation. The 
average age of patients who had been hospitalized with AMI in 2009/11 was nearly 5 
years younger than the average age of patients hospitalized in 2001/03.  Furthermore, 
approximately two thirds of the patients hospitalized in 2009 and 2011 were less than 75 
years old compared with slightly more than one half of the patients hospitalized in prior 
study years, reflecting a relatively dramatic shift in the age distribution of patients 
hospitalized with a first AMI.  
 
This shift to a younger age at the time of diagnosis in our patient population is in contrast 
to those observed in the Cardiovascular Research Network 14, in which there were no 
     16 
significant changes in the age profile of patients hospitalized with a first AMI between 
2000 and 2008. Similarly, investigators from the Rochester Epidemiology project 
reported little change in the age distribution of patients hospitalized with a first AMI 
between 1987 and 2006 15.  
 
While the reasons underlying differences in the findings between the current study and 
other population-based studies are unknown, we believe they could be due, in part, to the 
introduction of novel biomarkers and the use of more sensitive diagnostic tests as well as 
differences in the sociodemographic and clinical characteristics of the respective study 
populations. If real, these changes could be a result of a worsening of the coronary risk 
factor profile among residents of the Worcester metropolitan area during the years under 
study, creating a younger vulnerable population at risk for acute coronary disease. 
However, we lack data to examine this and related hypotheses and further research needs 
to be done to determine the factors underlying these troubling findings. 
 
There have also been marked changes over time in the occurrence of clinically important 
chronic diseases in our patient population. We observed increases in the proportion of 
patients previously diagnosed with anemia, chronic kidney disease, hyperlipidemia, 
hypertension, and peripheral vascular disease. This shift in patient profile toward the 
admission of predominantly younger patients with a greater prevalence of serious 
comorbidities could be secondary to changes in clinical-guidelines for the identification 
of patients with various chronic conditions that took place during the years under study. 
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New hypertension guidelines for the classification, prevention, and management of 
patients with elevated blood pressure were updated in 2003 while revised cholesterol 
guidelines management were released in 2004 16, 17. These updates could have potentially 
increased disease awareness among practicing physicians, leading to increases in 
detection and diagnosis. These trends could also be the result of meaningful changes in 
patient’s comorbidity profiles. The observed increases in various comorbidities in our 
study population were similar to those observed in by the Cardiovascular research 
Network (CVRN) in which significant increases over time in the proportion of patients 
diagnosed with hypertension and dyslipidemia were observed 18, but in partial contrast 
with those noted in the Minnesota Heart Survey in which the proportion of patients 
hospitalized with an incident AMI with previously diagnosed hypertension markedly 
declined 6. We observed a steady decline in the average  length of hospital stay for 
residents of the Worcester metropolitan area hospitalized with a first AMI over time, 
most likely due to improved treatment strategies and cost considerations 19.  
 
We found that patients with an incident AMI were more likely to have developed a Non-
ST-segment elevation myocardial infarction diagnosed during the years under study. 
These results are in contrast with some population-based studies 14, but are consistent 
with trends observed in the Rochester epidemiology project during a relatively similar 
study period 8.  Our data also show that the levels of Troponin I decreased considerably 
among patients hospitalized with a first AMI between 2001 and 2011. Although this 
could be an artifact created by the introduction of high-sensitivity troponin assays and 
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new test guidelines, the lower serum troponin levels observed in our patient population 
over time and the increasing proportion of smaller infarcts, as reflected by patient’s serial 
ECG findings, may be suggestive of a progressive decline in the severity of patients 
hospitalized with a first AMI at all medical centers in central Massachusetts  during the 
decade long period under study. 
 
Trends in hospital medication practices and coronary interventions. A number of 
community-based studies, including previous reports from the Worcester Heart Attack 
Study 4, 5, 7, 14, as well as large-scale coronary disease registries 18, have shown evidence 
of a progressive and sustained increase over time in the prescribing of effective cardiac 
therapies in patients hospitalized with AMI during the past two decades. We observed 
progressive increases in the percentage of patients receiving effective in-hospital 
therapies for AMI including aspirin, beta-blockers, and lipid lowering medications. These 
data demonstrate the increasing adherence of health care providers in central 
Massachusetts to guideline-recommended medications. Moreover, a gradual reduction in 
the utilization of cardiac medications with questionable therapeutic value or a narrow 
therapeutic/toxic ratio was also observed (e.g., calcium channel blockers and digoxin).  
 
Increases over the decade long period under study in the proportion of patients that 
underwent nonsurgical revascularization and diagnostic procedures were observed. These 
findings are consistent with evidence-based guidelines for the management of patients 
hospitalized with AMI, which recommend early percutaneous coronary intervention as 
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the preferred reperfusion therapy and the use of CABG as an alternative for patients with 
cardiogenic shock, high-risk anatomy, or a failed PCI. As new treatment 
recommendations and approaches evolve further over time, it remains of importance to 
monitor trends in the management of patients hospitalized with AMI and factors 
associated with different treatment approaches and patient’s long-term outcomes.  
 
Trends in hospital clinical complications and death. A marked change over time in the 
occurrence of clinically important AMI related complications was observed in our patient 
population.  We found a significant reduction in the proportion of patients who developed 
atrial fibrillation, heart failure, and ventricular fibrillation following an incident AMI. 
These meaningful changes in important and serious clinical  complications are consistent 
with the trends reported in  several  large population-based studies including the  New 
Jersey Myocardial Infarction Data Acquisition System (MIDAS)  and the OACIS 
prospective study 20,21, 22. 
 
We also documented a significant increase in the in-hospital survival of patients 
hospitalized with AMI in the Worcester metropolitan area, a finding consistent with prior 
reports from this study during earlier time periods 4, 5. These findings are also consistent 
with those derived from population-based studies in Northern California and 
Minneapolis/St Paul, Minnesota 7, 14. Several studies in Canada, European countries, and 
Australia have also shown increases over time in the short-term survival rates of patients 
hospitalized with AMI 23-25. 
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The encouraging declines in the hospital death rate of patients who had been hospitalized 
with an initial AMI observed over the past several decades could be a result of declines in 
the occurrence of common AMI complications. changes in the severity of the acute 
coronary episode, as well as due to the increased use of effective cardiac interventions 
and medications during the years under study.  
 
Study Strengths and limitations 
The strengths of the present investigation include the study of a large community-based 
population of patients hospitalized with a confirmed initial AMI at all central 
Massachusetts medical centers,  and an examination of   decade long trends in the 
occurrence of patient’s demographic characteristics, therapeutic interventions, and in-
hospital outcomes. The study was carried out in men and women of all ages from a well-
defined metropolitan area with demographic characteristics similar to U.S. residents. 
However, this study has several limitations, which must be kept in mind when 
interpreting our study results. Our study cohorts were comprised largely of Caucasians 
and thus may lack generalizability to other race/ethnic groups. The present study only 
included patients who were hospitalized with a first AMI. The influence of possible 
changes over time in the magnitude of out-of-hospital deaths due to cardiac disease or 
changes in the occurrence of silent unrecognized AMIs on the characteristics and 
outcomes of patients hospitalized with AMI remains unknown.  
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Conclusions. The results of this community-based study highlight the changing nature of 
the demographic characteristics, clinical landscape, and management of patients 
hospitalized with incident AMI at all medical centers in central Massachusetts. 
Disconcertingly, and meriting further surveillance, we observed a shift to a younger age 
at the time of first AMI diagnosis in our patient population. On the other hand, 
concomitant with progressive increases in the proportion of patients receiving effective 
evidence-based in-hospital therapies and coronary revascularization procedures, we 
observed a gradual decline in the occurrence of serious AMI complications and hospital 
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